Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy.
The Prostate（2023）
摘要
NLR provides prognostic information in the setting of patients with mCRPC receiving treatment with PSMA-TRT.
更多查看译文
关键词
Prostate cancer, PSA, PSMA-targeted radioligand therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要